Dongsheng Xi'an Hi-tech Group Co., Ltd. is a high-tech pharmaceutical industry area as the main large conglomerates, but also the domestic pharmaceutical industry has an influence on brands. Group, which owns a pharmaceutical companies, a national pharmaceutical production base and a post-doctoral mobile stations. Currently, the company employs more than 4,000, the total assets of nearly 50 billion yuan in 2007, Dongsheng Technology Industry Group total revenue of 40 billion yuan.

Dongsheng Group wholeheartedly focus on human health, since the end of 1996 involved in the pharmaceutical industry has been through a series of asset restructuring, and many domestic pharmaceutical companies to achieve strong joint, made pharmaceutical research and development, production and marketing of powerful advantage. Which, with the German company Bayer Co., Ltd. on its Pharmaceutical Co., Ltd. Jiangsu Qidong Gaitianli merger, creating the largest one cross-border transactions of property rights case.

2005 At the beginning, Dongsheng Group size up the situation into the second start-enterprise development, through the reorganization and optimization of internal resources, through a positive business growth and business ideas of change and adjustment, bigger and stronger business development goals.

build a pharmaceutical industry in the future development of strategies, Dongsheng Dongsheng Group will be listed as the core technology platform for industrial development, traditional Chinese medicine, modern medicine, fine anesthetic for the strategic development centers, to foster a competitive international business venture as the eternal dream of the "open, financial intelligence, cooperation, beyond the" corporate culture, inspired, writing Dongsheng new glory.

Since 1987 the founder Mr. Guo Jiaxue Dongsheng the business started to resign, along with the development of China's reform and opening up, Dongsheng has gone through 16 years of history. However, if the official involved in the pharmaceutical industry from Dongsheng date, then only a short seven-year history; in China's pharmaceutical market, Dongsheng also is a young company, but the young company in today's ever-changing pharmaceutical market growth to have an influence on brands. In this sense, Dongsheng is a progressive business.